These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 71202)

  • 21. Macrophage production by the bone marrow of tumor-bearing mice.
    Baum M; Fisher B
    Cancer Res; 1972 Dec; 32(12):2813-7. PubMed ID: 4644210
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating tumor antigens versus immune serum factors in depressed concomitant immunity.
    Vaage J
    Cancer Res; 1974 Nov; 34(11):2979-83. PubMed ID: 4425091
    [No Abstract]   [Full Text] [Related]  

  • 23. Evolution of cell-mediated immunity in mice bearing tumors produced by a mammary carcinoma cell line. Influence of tumor growth, surgical removal, and treatment with irradiated tumor cells.
    Le François D; Youn JK; Belehradek J; Barski G
    J Natl Cancer Inst; 1971 May; 46(5):981-7. PubMed ID: 5157849
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of lymphoid cells responding to virus- and tumor-associated antigens in spleens of syngeneic mouse mammary tumor systems with low and high oncogenic potentials.
    Lopez DM; Paul RD
    J Natl Cancer Inst; 1982 Dec; 69(6):1403-9. PubMed ID: 6292565
    [No Abstract]   [Full Text] [Related]  

  • 25. [Transplantation immunity to a UV-induced murine sarcoma by injection of a glycoprotein fraction from the tumor].
    Pasternak L; Ristau E
    Arch Geschwulstforsch; 1985; 55(1):17-21. PubMed ID: 3985765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3. I. Transplantability, morphology, and some physicochemical characteristics.
    Friberg S
    J Natl Cancer Inst; 1972 May; 48(5):1463-76. PubMed ID: 5030958
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlation of tumor growth and cell-mediated immune responses of mice bearing mammary tumors following surgical procedures.
    Lopez DM; Sigel MM
    J Reticuloendothel Soc; 1975 Nov; 18(5):305-12. PubMed ID: 1206665
    [No Abstract]   [Full Text] [Related]  

  • 28. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
    Black MM; Zachrau RE
    J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral & cell mediated immunity to leukemia specific antigens in an inbred mouse strain showing spontaneous leukemia & mammary tumors.
    Vissa B; Gangal SG
    Indian J Exp Biol; 1974 Jan; 12(1):12-4. PubMed ID: 4426641
    [No Abstract]   [Full Text] [Related]  

  • 30. [Solubilization of antigens from ATPC+ ascitic tumor using hypertonic sodium solution].
    Marconi P; Bistoni F; Pitzurra M
    Boll Soc Ital Biol Sper; 1973 May; 49(10):534-8. PubMed ID: 4132962
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro studies on tumor-specific immunity by using C3H mammary cancer-A cells. I. Inhibitory effect of lymph-node cells from the tumor bearing isologous C3H mouse on the proliferation of the tumor cells.
    Satoh K
    Acta Med Okayama (1952); 1966 Dec; 20(6):261-8. PubMed ID: 4227190
    [No Abstract]   [Full Text] [Related]  

  • 32. Growth stage-dependent sialylation of tumor-associated embryonic substances on mouse ascites tumor cells.
    Saito M; Tanino T; Egawa K
    Jpn J Exp Med; 1980 Jun; 50(3):189-96. PubMed ID: 7431676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attempts to obtain monoclonal antibody against MMTV tumors.
    Tax A; Manson LA
    Transplant Proc; 1980 Sep; 12(3):391-3. PubMed ID: 6261429
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice.
    Bekesi JG; Roboz JP; Holland JF
    Isr J Med Sci; 1976; 12(4-5):288-303. PubMed ID: 181351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
    Blair PB; Lane MA
    J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated growth of mammary tumor cells in normal and athymic mice after treatment in vitro with dexamethasone.
    Gillette RW; Wunderlich DA
    Cancer Res; 1978 Oct; 38(10):3146-9. PubMed ID: 80260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A tumour-associated membrane antigen transiently expressed by normal cells during mitosis.
    Bertini M; Forni G; Comoglio PM
    Clin Exp Immunol; 1974 Sep; 18(1):101-8. PubMed ID: 4468189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic studies with mouse mammary tumor viruses: comparative studies with spontaneous mammary tumor cell vaccines from five inbred mouse strains.
    Girardi AJ; Dion AS; Holben JA
    J Natl Cancer Inst; 1985 Jan; 74(1):105-12. PubMed ID: 2982052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue culture studies of mouse mammary tumor cells and associated viruses.
    Owens RB; Hackett AJ
    J Natl Cancer Inst; 1972 Nov; 49(5):1321-32. PubMed ID: 4346536
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells.
    Shimizu J; Suda T; Yoshioka T; Kosugi A; Fujiwara H; Hamaoka T
    J Immunol; 1989 Feb; 142(3):1053-9. PubMed ID: 2464022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.